H
Hazel R. Scott
Researcher at Wishaw General Hospital
Publications - 12
Citations - 1423
Hazel R. Scott is an academic researcher from Wishaw General Hospital. The author has contributed to research in topics: Performance status & Weight loss. The author has an hindex of 10, co-authored 12 publications receiving 1276 citations. Previous affiliations of Hazel R. Scott include National Health Service.
Papers
More filters
Journal ArticleDOI
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
Donald C. McMillan,Walter S. Watson,Patricia O'Gorman,Tom Preston,Hazel R. Scott,Colin S. McArdle +5 more
TL;DR: The interrelationship between albumin, body cell mass, and the inflammatory response is consistent with the concept that the presence of an ongoing inflammatory response contributes to the progressive loss of these vital protein components of the body and the subsequent death of patients with advanced cancer.
Journal ArticleDOI
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
Hazel R. Scott,Donald C. McMillan,L M Forrest,Duncan J.F Brown,Colin S. McArdle,Robert Milroy +5 more
TL;DR: The results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response and an increase in the magnitude of the systemicinflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survival.
Journal ArticleDOI
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
TL;DR: Markers of the inflammatory response, interleukin 6, C-reactive protein, albumin and full blood count, were measured in non-small-cell lung cancer patients with and without weight loss, consistent with interleucin 6 and the acute phase response promoting weight loss in NSCLC.
Journal ArticleDOI
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.
TL;DR: The value of an inflammation-based prognostic score (Glasgow Prognostic score, GPS) was compared with performance status (ECOG-ps) in a longitudinal study of patients with inoperable non-small-cell lung cancer, and only the GPS was a significant predictor of survival.
Journal ArticleDOI
Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients
Donald C. McMillan,Hazel R. Scott,Walter S. Watson,Tom Preston,Robert Milroy,Colin S. McArdle +5 more
TL;DR: This study demonstrates the association of a chronic inflammatory response with the rate of loss of body cell mass observed in cancer patients.